Cargando…

A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria

Urticaria is a heterogeneous group of disorders, especially acute urticaria and angiooedema can be a medical emergency. This paper summarizes the EAACI/GA(2)LEN/EDF/WAO guidelines, the most recent international guidelines from 2009. Patients with urticaria are often not diagnosed and treated appropr...

Descripción completa

Detalles Bibliográficos
Autor principal: Zuberbier, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488932/
https://www.ncbi.nlm.nih.gov/pubmed/23282889
http://dx.doi.org/10.1186/1939-4551-5-S1-S1
_version_ 1782248698467581952
author Zuberbier, Torsten
author_facet Zuberbier, Torsten
author_sort Zuberbier, Torsten
collection PubMed
description Urticaria is a heterogeneous group of disorders, especially acute urticaria and angiooedema can be a medical emergency. This paper summarizes the EAACI/GA(2)LEN/EDF/WAO guidelines, the most recent international guidelines from 2009. Patients with urticaria are often not diagnosed and treated appropriately and the guidelines state that clinicians should always aim to provide complete symptom relief. The mainstay of urticaria treatment is the use of modern nonsedating antihistamines, if required up to 4-fold of standard doses.
format Online
Article
Text
id pubmed-3488932
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-34889322012-11-28 A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria Zuberbier, Torsten World Allergy Organ J Symposium Report Supplement Urticaria is a heterogeneous group of disorders, especially acute urticaria and angiooedema can be a medical emergency. This paper summarizes the EAACI/GA(2)LEN/EDF/WAO guidelines, the most recent international guidelines from 2009. Patients with urticaria are often not diagnosed and treated appropriately and the guidelines state that clinicians should always aim to provide complete symptom relief. The mainstay of urticaria treatment is the use of modern nonsedating antihistamines, if required up to 4-fold of standard doses. World Allergy Organization 2019-04-30 /pmc/articles/PMC3488932/ /pubmed/23282889 http://dx.doi.org/10.1186/1939-4551-5-S1-S1 Text en Copyright © 2012 by World Allergy Organization. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Symposium Report Supplement
Zuberbier, Torsten
A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria
title A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria
title_full A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria
title_fullStr A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria
title_full_unstemmed A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria
title_short A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria
title_sort summary of the new international eaaci/ga(2)len/edf/wao guidelines in urticaria
topic Symposium Report Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488932/
https://www.ncbi.nlm.nih.gov/pubmed/23282889
http://dx.doi.org/10.1186/1939-4551-5-S1-S1
work_keys_str_mv AT zuberbiertorsten asummaryofthenewinternationaleaaciga2lenedfwaoguidelinesinurticaria
AT zuberbiertorsten summaryofthenewinternationaleaaciga2lenedfwaoguidelinesinurticaria